AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 94 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,829,529 | -23.4% | 39,781 | -4.3% | 0.04% | -19.1% |
Q2 2023 | $2,388,626 | +51.1% | 41,563 | -1.4% | 0.05% | +56.7% |
Q1 2023 | $1,581,300 | +22.3% | 42,168 | -8.6% | 0.03% | +20.0% |
Q4 2022 | $1,293,067 | -29.8% | 46,148 | -29.6% | 0.02% | -32.4% |
Q3 2022 | $1,842,000 | -29.0% | 65,536 | -12.1% | 0.04% | -21.3% |
Q2 2022 | $2,596,000 | -13.1% | 74,574 | -10.3% | 0.05% | +4.4% |
Q1 2022 | $2,986,000 | +25.6% | 83,136 | -18.5% | 0.04% | +50.0% |
Q4 2021 | $2,377,000 | +13.6% | 102,002 | -7.3% | 0.03% | +11.1% |
Q3 2021 | $2,092,000 | +109.8% | 109,987 | +122.6% | 0.03% | +145.5% |
Q2 2021 | $997,000 | +179.3% | 49,417 | +154.5% | 0.01% | +175.0% |
Q1 2021 | $357,000 | -10.3% | 19,417 | -1.5% | 0.00% | -20.0% |
Q4 2020 | $398,000 | -79.3% | 19,717 | -80.8% | 0.01% | -78.3% |
Q3 2020 | $1,923,000 | -59.8% | 102,517 | -51.8% | 0.02% | -58.9% |
Q2 2020 | $4,781,000 | +51.3% | 212,830 | +0.0% | 0.06% | +33.3% |
Q1 2020 | $3,159,000 | -21.9% | 212,817 | +1.5% | 0.04% | +2.4% |
Q4 2019 | $4,045,000 | -4.9% | 209,638 | -2.2% | 0.04% | -4.7% |
Q3 2019 | $4,254,000 | +0.4% | 214,444 | +6.8% | 0.04% | -2.3% |
Q2 2019 | $4,238,000 | -5.9% | 200,738 | -8.9% | 0.04% | -10.2% |
Q1 2019 | $4,505,000 | +11.1% | 220,438 | +8.2% | 0.05% | -9.3% |
Q4 2018 | $4,055,000 | +99.5% | 203,746 | +92.9% | 0.05% | +125.0% |
Q3 2018 | $2,033,000 | +47.0% | 105,629 | +44.9% | 0.02% | +14.3% |
Q3 2016 | $1,383,000 | +32.6% | 72,903 | +12.7% | 0.02% | +23.5% |
Q2 2016 | $1,043,000 | -3.7% | 64,700 | -28.3% | 0.02% | -19.0% |
Q1 2016 | $1,083,000 | -15.7% | 90,225 | 0.0% | 0.02% | -25.0% |
Q4 2015 | $1,284,000 | +19.6% | 90,225 | -1.7% | 0.03% | +7.7% |
Q3 2015 | $1,074,000 | +115.7% | 91,822 | +224.4% | 0.03% | +116.7% |
Q2 2015 | $498,000 | – | 28,309 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
Summit Global Investments | 47,546 | $871,000 | 0.06% |
WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |